POLH and cancer: HU evolved cells exhibited a predominant signature of SBS9 (single base substitutions 9) and ID8 (small insertions and deletions 8), which in cancers is characteristic of DNA polymerase eta (Pol η) somatic hypermutation activity and repair of DNA double strand breaks by non-homologous end joining (NHEJ).